Ponatinib Recruiting Phase N/A Trials for Chronic Myeloid Leukemia (CML) / Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

IndicationsStatusPurposePhase
RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03709017Iclusig PMS in CML or Ph+ALL Patients